First integrase inhibitor Isentress gets regulatory green light
Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Accelerated approval for Merck's raltegravir (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
